Trillium Asset Management, Llc
Source: SEC Form 13F · as of Mar 2026Trillium Asset Management, Llc holds 17 biotech & pharma companies tracked by BioSniper, totaling $128.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$128.5M
| Company | Shares | Value |
|---|---|---|
| AZNASTRAZENECA PLC | 263,507 | $44.4M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 99,762 | $28.1M |
| GILDGILEAD SCIENCES, INC. | 81,412 | $11.3M |
| MRKMerck & Co., Inc. | 91,372 | $11.0M |
| ELVElevance Health Inc. | 22,302 | $6.4M |
| MMSIMerit Medical Systems Inc. | 79,606 | $6.0M |
| NVONovo Nordisk A/S | 145,602 | $5.9M |
| DGXQuest Diagnostics Incorporated | 23,631 | $5.0M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 34,719 | $4.2M |
| JNJJOHNSON & JOHNSON | 11,584 | $2.8M |
| IQVIQVIA Holdings Inc. | 4,219 | $720K |
| ABBVAbbVie Inc. | 2,853 | $620K |
| ABTABBOTT LABORATORIES | 5,599 | $575K |
| PFEPFIZER INC | 15,799 | $444K |
| LLYELI LILLY & Co | 365 | $336K |
| AMGNAMGEN INC | 729 | $256K |
| BMYBRISTOL MYERS SQUIBB CO | 3,612 | $219K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.